Establishment Labs Holdings Inc. (ESTA): BTIG Considers the Motiva Breast Implant to be a “Disruptive Technology”

Establishment Labs Holdings Inc. (ESTA) operates in the highly regulated medical technology market. New approvals, but also delays or regulatory restrictions (e.g. FDA changes to implant regulations) can have a direct impact on the valuation. The competitive situation (e.g. against manufacturers such as Johnson & Johnson or Allergan) is also relevant for the market position. The commercialization of Motiva products on the US market is a key growth driver. The USA is the largest market for aesthetic breast implants. The positive trends were...